Journal
CELL METABOLISM
Volume 22, Issue 6, Pages 1078-1089Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2015.09.023
Keywords
-
Categories
Funding
- National Health and Medical Research Council of Australia [1061278, 606766, APP1021168, 1059454, 606460, 1077703]
- Diabetes Australia Research Trust
- Monash University
- National Health and Medical Research Council of Australia [1061278, 1077703] Funding Source: NHMRC
Ask authors/readers for more resources
Liver steatosis is associated with the development of insulin resistance and the pathogenesis of type 2 diabetes. We tested the hypothesis that protein signals originating from steatotic hepatocytes communicate with other cells to modulate metabolic phenotypes. We show that the secreted factors from steatotic hepatocytes induce pro-inflammatory signaling and insulin resistance in cultured cells. Next, we identified 168 hepatokines, of which 32 were differentially secreted in steatotic versus non-steatotic hepatocytes. Targeted analysis showed that fetuin B was increased in humans with liver steatosis and patients with type 2 diabetes. Fetuin B impaired insulin action in myotubes and hepatocytes and caused glucose intolerance in mice. Silencing of fetuin B in obese mice improved glucose tolerance. We conclude that the protein secretory profile of hepatocytes is altered with steatosis and is linked to inflammation and insulin resistance. Therefore, preventing steatosis may limit the development of dysregulated glucose metabolism in settings of overnutrition.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available